Thalidomide (HAL) maintenance following high-dose melphalan with autologous stem cell transplant (ASCT) for myeloma.

被引：0
|
作者：
Chang, Julie E. [1 ]
Juckett, Mark B. [1 ]
Kahl, Brad. S. [1 ]
Mitchell, Teri L. [1 ]
Gangnon, Ronald E. [1 ]
Callander, Natalie S. [1 ]
Longo, Walter L. [1 ]
机构：
[1] Univ Wisconsin, Dept Hematol & Bone Marrow Transplantat, Madison, WI USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.5455.5455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5455
引用
收藏
页码：459B / 459B
页数：1
相关论文
共 50 条
  • [41] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [42] MAINTENANCE THERAPY WITH LOW DOSE THALIDOMIDE, DEXAMETHASONE AND CLARITHROMYCIN (BLT-D) FOLLOWING AUTOLOGOUS TRANSPLANT (ASCT) FOR MULTIPLE MYELOMA (MM)
    Holmberg, L.
    Gooley, T.
    Becker, P.
    Maloney, D.
    Bensinger, W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S251 - S251
  • [43] Arsenic trioxide with ascorbic acid and high-dose melphalan: A new preparative regimen for autologous hematopoietic stem cell transplantation for multiple myeloma.
    Qazilbash, MH
    Davis, MS
    Ana, A
    Roden, L
    Libunao, F
    Tball, PF
    Wang, XM
    Couriel, D
    De Lima, M
    Hosing, C
    Kebriaei, P
    Weber, D
    Wang, M
    Jones, RB
    Matthes, SG
    Champlin, RE
    Giralt, SA
    BLOOD, 2005, 106 (11) : 338A - 339A
  • [44] Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
    Vogl, Dan T.
    Liu, Stephen V.
    Chong, Elise A.
    Luger, Selina M.
    Porter, David L.
    Schuster, Stephen J.
    Tsai, Donald E.
    Perl, Alexander
    Loren, Alison W.
    Goldstein, Steven C.
    Nasta, Sunita D.
    Andreadis, Charalambos
    Mangan, Patricia A.
    Hummel, Kimberly
    Siegel, Don L.
    Glatstein, Eli
    Stadtmauer, Edward A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (12) : 1071 - 1075
  • [45] Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma
    Olin, RL
    Luger, SM
    Porter, DL
    Schuster, SJ
    Tsai, D
    Nasta, S
    Perl, A
    Loren, AW
    Goldstein, S
    Mangan, P
    Sherry, V
    Cunningham, K
    Sachs, B
    Hummel, K
    Stadtmauer, EA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 87 - 87
  • [46] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [47] Changes in serum free light chain concentrations after high-dose melphalan and autologous stem cell transplant in myeloma patients
    Mead, G
    Bradwell, AR
    Lovell, R
    Pratt, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S10 - S10
  • [48] Cryotherapy in adult patients with myeloma treated with high-dose melphalan and autologous stem cell transplant: preliminary results of randomized study
    Marchesi, F.
    Tendas, A.
    Viggiani, C.
    Gumenyuk, S.
    Renzi, D.
    Franceschini, L.
    Caffarella, G.
    Rizzo, M.
    Palombi, F.
    Pisani, F.
    Romano, A.
    Spadea, A.
    Papa, E.
    Canfora, M.
    Cantonetti, M.
    Arcese, W.
    Mengarelli, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S36 - S36
  • [49] Impact of concurrent gabapentin or pregabalin with high-dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant
    Sivakumar, Akhilesh
    Bryson, Evan B.
    Hall, Kevin H.
    Maples, Kathryn T.
    Goyal, Subir
    Joseph, Nisha S.
    Hofmeister, Craig C.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay K.
    Harvey, Robert Donald
    PHARMACOTHERAPY, 2022, 42 (03): : 233 - 240
  • [50] TIMING OF HIGH DOSE MELPHALAN (HDM) AND OUTCOMES FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH MULTIPLE MYELOMA (MM)
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Sobecks, R.
    Pohlman, B.
    Andresen, S.
    Earl, M.
    Dean, R.
    Copelan, E.
    Kalaycio, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 41 - 42
12345